Additional file 1.
Table 1:Clinicopathologic characteristics of NSCLC patients and tumors examined.Table 2: Treatment-related patient groups and outcome. Table 3: Selection of the normal RQ value range was based on the highest frequency of RQ values within a 3-cycle range in the normal sample series. Table 4: Initial classification of B, E, R, T RQ values in NSCLC tumors. Figure 1: PFS patterns of patients in Subgroup B (1st line, chemo-naïve + pre-treated) with mRNA RQ values classified in a 3-scale as low, normal and high. Figure 2: Significant but non-specific associations of BRCA1 and RRM1 gene expression with the outcome of 1st line chemo-naïve patients treated with taxanes excluding the platinum doublet. Figure 3: Effect of ERCC1 mRNA expression on the outcome of 1st line chemo-naïve treated patients.
Format: PDF Size: 394KB Download file
This file can be viewed with: Adobe Acrobat Reader
Kotoula et al. BMC Cancer 2012 12:342 doi:10.1186/1471-2407-12-342